Pro-fluoxetine: Affected Lots Exceed The Interim Acceptable Intake Limit For N-nitroso-fluoxetine.

Pro-Fluoxetine tablets distributed across Canada are being recalled because certain batches contain higher-than-acceptable levels of N-nitroso-fluoxetine, a substance that can form during drug manufacturing. This is a Class I recall, meaning the product poses a potential health risk. The recall affects all Pro-Fluoxetine products distributed in Canada.

Product
PRO-FLUOXETINE
Reason
Product quality
Classification
Class I
Category
drug recall
Country
Canada
Agency
HC-DRUGS
Recall date
2025-04-28
Status
Ongoing
Distribution
Canada-wide

Official recall notice from HC-DRUGS

Recall details on Nibble Recalls: https://trynibble.app/recalls/7062cffd-8b80-47fd-a3a8-ea7b7f065215